Search This Blog

Wednesday, June 26, 2019

AbbVie to secure $38B bridge loan for Allergan transaction

Bloomberg reports that AbbVie (NYSE:ABBV) intends to syndicate a $38B 364-day bridge loan for its acquisition of Allergan (NYSE:AGN).
Both stocks are up 1% premarket on light volume.
Update: AbbVie’s bond offering to finance the transaction could reach $30B according to CreditSights, the fourth largest U.S. dollar-denominated debt deal of all time.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)